-
Notifications
You must be signed in to change notification settings - Fork 2
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
BRIDG Mappings for Specimen elements about the anatomical source #2
Comments
One possibility for BRIDG supporting this interpretation is to use the BRIDG "BiologicEntityPart" class:
Using BiolicEntityPart, the mapping path for all* of these ADM elements that are ostensibly about the anatomical source would look something like this:
and
* Exceptions include the biospecimen anatomic site and biospecimen laterality elements, as the Biologic Entity Part class has dedicated/explicit attributes to capture info related to location ** At present BRIDG does not allow BiologiEntityParts to be Subjects of PerformedActivities (only Biologic Entities, and Biologic Entity Groups, and Products, and Specimens) - but I think this should be changed. |
Looking ahead to our harmonized CRDC-H model, we might consider a class representing the anatomical source concepts. Representing the source anatomical entity/tissue as a separate/independent object from the extracted specimen would allow us to talk more clearly about characteristics of observations about the source tissue in the context of the source organism
. . . .and any other elements annotated/categorized as being about the Anatomical source |
The definition of the
ADM.Sample.general_sample_pathology
element suggests that the subject of the observation here is the anatomic source of the specimen, not the specimen itself (what type of tissue the specimen was derived/taken from):Is there any way in BRIDG to represent the anatomical source/tissue as the subject of the observation here? i.e. can we represent the source tissue in the organism as a specimen, that is separate from the extracted specimen - an observed specimen in situ vs an extracted material specimen in vitro)
And more generally, for all elements classified as being about anatomic source/biological source . . . should the mapping path for these make the subject of observations (and perhaps the root of the Mapping path) be the source material, not the specimen (if we consider the specimen to be the material once taken out of the source)
Here are a list of elements in Sample that I would say are about this anatomical source, rather than the specimen itself:
Another general issue this may raise is the distinction between observations about a samples made during collection (while it is still in vivo), as being distinct from observations made after extraction, typically by a pathologist, that may confirm (or refute or extend or qualify) the observation that was made earlier during extraction. This is a common phenomenon, and we need a clear and consistent way to represent it. Being able to represent the anatomic source of a specimen separately from the extracted specimen would be one way to support this (assuming there is a way to capture the derivation relationship between them)
The text was updated successfully, but these errors were encountered: